Human leukocyte antigen system and the immune response to it

Clinical Orthopaedics and Related Research

Volumn 326, Issue , 1996, Pages 35-42

  Nelson, Karen A ^a  

^a PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HUMORAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; BONE ALLOGRAFT; CHROMOSOME 6P; CONFERENCE PAPER; DNA POLYMORPHISM; GRAFT REJECTION; HISTOCOMPATIBILITY; HLA MATCHING; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0029979601     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199605000-00005     Document Type: Conference Paper

References (53)

1. Ajitkuar P, Geier SS, Kesari KV, et al: Evidence that multiple residues on both the alpha helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell 54:47-54, 1989.
2. Allen PM, Matsueda GR, Evans RJ, et al: Identification of the T-cell and Ia contact residues for a T-cell antigenic epitope. Nature 327:713-715, 1987.
3. Anderson CB, Brennan DC: A sanguine outlook: The role of donor-specific transfusions in renal transplantation and tolerance. Transpl Rev 9:49-62, 1995.
4. Ayoub G, Terasaki P: HLA-DR matching in multicenter, single-typing laboratory data. Transplantation 33:515-520, 1982.
5. Bach F, Hirschorn K: Lymphocyte interaction: A potential histocompatibility test in vitro. Science 143:813-814, 1964.
6. Batchelor JR, Lombardi G, Lechler RI: Speculations on the specificity of suppression. Immunol Today 10:37-40, 1989.
7. Bell JI, Todd JA, McDevitt HO: Molecular Structure of Human Class II Antigens. In Dupont B (ed). Immunobiology of HLA. Vol 2B. New York, Springer-Verlag 44-48, 1989.
8. Benichou G, Takizawa PA, Olson CA, McMilan M, Secarz EE: Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 175:918-924, 1992.
9. Bjorkman PJ, Parham P: Structure, function and diversity of class I histocompatibility complex molecules. Ann Rev Biochem 59:253-288, 1990.
10. Bjorkman PJ, Saper MA, Samraoui B, et al: The foreign antigen-binding site and T-cell recognition regions of class I histocompatibility antigens. Nature 329:512-518, 1987.
11. Bjorkman PJ, Saper MA, Samraoui B, et al: Structure of human class I histocompatibility antigen, HLA-A2. Nature 329:506-512, 1987.
12. Bodmer JG, Marsh SGE, Albert ED, et al: Nomenclature for factors of the HLA system, 1994. Tissue Antigens 44:1-8, 1994.
13. Brent L: Tolerance: Past, present and future. Transplant Proc 23:2056-2060, 1991.
14. Brodsky FM, Gugliardi J: The cell biology of antigen processing and presentation. Ann Rev Immunol 9:707-744, 1991.
15. Chen BP, Parham P: Binding of influenza peptides to class I HLA molecules. Nature 337:743-745, 1989.
16. Collins T, Korman AJ, Wake CT, et al: Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 81:4917-4921, 1984.
17. Conrad EU, Bruckner JD, Hoekema J, Cusick K, Nelson K: Clinical and immunological evaluation of allograft transplantation for malignant and aggressive bone tumors. Proc 8th Intl Symp on Limb Salvage 16, 1995.
18. Daar AS, Fuggle SV, Fabre JW, et al: The detailed distribution of HLA-A,B,C, antigens in normal human organs. Transplantation 38:27-292, 1984.
19. Daar AS, Fuggle SV, Fabre JW, et al: The detailed distribution of MHC class II antigens in normal human organs. Transplantation 38:293-298, 1984.
20. Dausset J: Leuco-agglutinins IV. Leuco-agglutinins and blood transfusion. Vox Sang (Amsterdam) 4:190-198, 1954.
21. Davidson HW, Reid PA, Lanzavecchia A, Watts C: Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell 67:105-116, 1991.
22. David-Watine B, Israel A, Kourilsky B: The regulation and expression of MHC class I genes. Immunol Today 11:286-292, 1990.
23. Duquesnoy RJ, White L, Fierst J, et al: Multiscreen Analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Transplantation 50:427-437, 1990.
24. Erlich H, Stetler D, Sheng-Dong R, et al: Analysis by molecular cloning of human class II genes. Fed Proc 43:3025-3030, 1984.
25. Gershon R: T cell control of antibody production. Contemp Top Immunobiol 3:1-40, 1974.
26. Gorer P: The detection of antigenic differences in mouse erythrocytes by the employment of immune sera. Br J Pathol 17:42-50, 1936.
27. Horsburgh T, Wood PJ, Brent L: In vivo induction of specific suppressor lymphocytes to histocompatibility antigen. Transplant Proc 13:637-639, 1983.
28. Kappler JW, Roehm N, Marrack P: T cell tolerance by clonal elimination in the thymus. Cell 49: 273-280, 1987.
29. Kelly A, Powis SH, Kerr LA, et al: Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 335:641-644, 1992.
30. Kieslow P, Sia Teh H, Bluthman H, et al: Positive selection of antigen-specific T cells in the thymus by restricting MHC molecules. Nature 335:730-733, 1988.
31. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O: Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 2:662-664, 1966.
32. Kwok W, Schwarz D, Nepom BS, et al: HLA-DQ molecules from αβ heterodimers of mixed allotype. J Immunol 141:3123-3127, 1988.
33. Lapierre LA, Fiers W, Pober JS: Three distinct classes of regulatory cytokines control endothelial cell MHC expression. J Exp Med 167:794-894, 1988.
34. Lee JS, Trowsdale J, Travers PJ, et al: Sequence of an HLA-DRa chain cDNA clone and intron-exon organization of the corresponding gene. Nature 299:750-752, 1982.
35. Marquet RL, Heyksek GA: Induction of suppressor cells by donor-specific blood transfusions and heart transplantation in rats. Transplantation 31:271-274, 1981.
36. Marrack P, Kappler JW: T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature 332:840-843, 1988.
37. McDevitt HO, Deak B, Shreffler D, et al: Genetic control of the immune response. Mapping of the Ir-1 locus. J Exp Med 135:1259-1278, 1972.
38. Nelson K, Hoekema J, Yadock W, et al: Humoral immunity to bone allografts: Development of IgG to donor alloantigens is associated with delayed union and poor function. Hum Immunol 40 (Suppl 1):8, 1994.
39. Nikaen A: American Society of Histocompatibility and Immunogenetics Laboratory Manual. Ed 3. Lenexa, KS 1994.
40. Ogura K, Terasaki PI, Johnson C, et al: The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation 56:294-298, 1993.
41. Parham P, Chen BP, Clayberger C, et al: Diversity of class I HLA molecules: Functional and evolutionary interactions with T cells. Cold Spring Harb Symp Quant Biol 54:529-543, 1989.
42. Payne R, Rolfs MR: Fetal-maternal leukocyte incompatibility. J Clin Invest 37:1756-1763, 1958.
43. Ploegh H, Orr H, Strominger J: Molecular cloning of a human histocompatibility antigen cDNA fragment. Proc Nat Acad Sci USA 77:6081-6085, 1980.
44. Stevenson S, Li XQ, Martin B. The fate of cancellous and cortical bone after transplantation of fresh and frozen tissue-antigen-matched and mismatched osteochondral allografts in dogs. J Bone Joint Surg 73A:1143-1156, 1991.
45. Strong DM, Friedlaender GE, Tomford WW, et al: Immunological responses in human recipients of osseous and osteochondral allografts. Clin Orthop 326:107-114, 1995.
46. Svejgaard A, Kissmeyer-Nielsen F: Crossreactive HL-A iso-antibodies. Nature 219:868-870, 1968.
47. Terasaki PI: Microdroplet Assay of Human Blood Lymphotoxins. Histocompatibility Testing. Washington, DC, National Academy of Sciences 171, 1985.
48. Terhorst C, Parham P, Mann D, et al: Structure of HLA antigens: Amino acid and carbohydrate compositions and NH2-terminal sequences of four antigen preparations. Proc Natl Acad Sci USA 73:910-914, 1976.
49. Trowsdale J, Ragoussis J, Campbell RD: Map of the human MHC. Immunol Today 12:443-446, 1991.
50. Van Rood JJ, VanLeeuven A: Leukocyte grouping: A method and its application. J Clin Invest 43:1382-1390, 1963.
51. Walny HJ, Rammensee HG: Identification of a classical minor histocompatibility antigen as a cell-derived peptide. Nature 343:275-278, 1990.
52. Williams GM, Hume D, Hudson R, et al: Hyperacute renal homograft rejection in Man. N Engl J Med 279:611-618, 1968.
53. Zinkernagel RM, Doherty PC: Restriction of in vivo T cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semi-allogeneic system. Nature 248:701-702, 1974.